menu
    • menu
    [{"orgOrder":0,"company":"PROFESSIONAL DISPOSABLES INTERNATIONAL","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2020","type":"Inapplicable","leadProduct":"Isopropyl Alcohol","moa":"Nitric oxide synthase 3; Oxysterols receptor LXR-beta; Heme oxygenase 1; GTP cyclohydrolase 1; Phospholipase A2, membrane associated; Tumor necrosis factor","graph1":"Infections and Infectious Diseases","graph2":"Phase III","graph3":"PROFESSIONAL DISPOSABLES INTERNATIONAL","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PROFESSIONAL DISPOSABLES INTERNATIONAL \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"PROFESSIONAL DISPOSABLES INTERNATIONAL \/ Undisclosed"},{"orgOrder":0,"company":"PROFESSIONAL DISPOSABLES INTERNATIONAL","sponsor":"PROFESSIONAL DISPOSABLES INTERNATIONAL","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"U.S.A","productType":"Miscellaneous","year":"2019","type":"Inapplicable","leadProduct":"Povidone Iodine","moa":"Undisclosed","graph1":"Infections and Infectious Diseases","graph2":"Phase IV","graph3":"PROFESSIONAL DISPOSABLES INTERNATIONAL","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"PROFESSIONAL DISPOSABLES INTERNATIONAL \/ PROFESSIONAL DISPOSABLES INTERNATIONAL","highestDevelopmentStatusID":"11","companyTruncated":"PROFESSIONAL DISPOSABLES INTERNATIONAL \/ PROFESSIONAL DISPOSABLES INTERNATIONAL"},{"orgOrder":0,"company":"PROFESSIONAL DISPOSABLES INTERNATIONAL","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase III","graph3":"PROFESSIONAL DISPOSABLES INTERNATIONAL","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Swab","sponsorNew":"PROFESSIONAL DISPOSABLES INTERNATIONAL \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"PROFESSIONAL DISPOSABLES INTERNATIONAL \/ Undisclosed"},{"orgOrder":0,"company":"PROFESSIONAL DISPOSABLES INTERNATIONAL","sponsor":"Undisclosed","pharmaFlowCategory":"DU","therapeuticArea":"Undisclosed","country":"U.S.A","productType":"Undisclosed","year":"2019","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Undisclosed","graph2":"Phase III","graph3":"PROFESSIONAL DISPOSABLES INTERNATIONAL","amount2":0,"highestDevelopmentShortName":"Ph III","therapeuticAreaShortName":"","amount2New":0,"dosageForm":"Swab","sponsorNew":"PROFESSIONAL DISPOSABLES INTERNATIONAL \/ Undisclosed","highestDevelopmentStatusID":"10","companyTruncated":"PROFESSIONAL DISPOSABLES INTERNATIONAL \/ Undisclosed"}]

    Find Clinical Drug Pipeline Developments & Deals by PROFESSIONAL DISPOSABLES INTERNATIONAL

    Menu

    PROFESSIONAL DISPOSABLES INTERNATIONAL

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            PROFESSIONAL DISPOSABLES INTERNATIONAL

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed

                            PROFESSIONAL DISPOSABLES INTERNATIONAL

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Isopropyl Alcohol

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Preoperative Skin Preparation Study to Evaluate the Antimicrobial Capabilities of Four Test Substances

                            Details : Isopropyl alcohol is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Surgical Wound Infection.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            January 06, 2020

                            Lead Product(s) : Isopropyl Alcohol

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            PROFESSIONAL DISPOSABLES INTERNATIONAL

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed

                            PROFESSIONAL DISPOSABLES INTERNATIONAL

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Povidone Iodine

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Phase IV

                            Recipient : University of Iowa

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Nasal Decolonization for Orthopedic Trauma Patients

                            Details : Povidone Iodine is a Other Small Molecule drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Surgical Wound Infection.

                            Product Name : Undisclosed

                            Product Type : Miscellaneous

                            Upfront Cash : Inapplicable

                            October 31, 2019

                            Lead Product(s) : Povidone Iodine

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Phase IV

                            Recipient : University of Iowa

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            PROFESSIONAL DISPOSABLES INTERNATIONAL

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed

                            PROFESSIONAL DISPOSABLES INTERNATIONAL

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Pilot Evaluation of Two Test Materials With a Positive Control When Used as a Patient Preoperative Skin Prepar...

                            Details : This drug candidate is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            March 04, 2019

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            PROFESSIONAL DISPOSABLES INTERNATIONAL

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed

                            PROFESSIONAL DISPOSABLES INTERNATIONAL

                            U.S.A arrow
                            OTS 2025
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Undisclosed

                            Study Phase : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            DEALS_DEV arrow-down

                            Comparative Study of Antimicrobial Effectiveness

                            Details : This drug candidate is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Inapplicable

                            January 25, 2019

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Undisclosed

                            Highest Development Status : Phase III

                            Sponsor : Undisclosed

                            Deal Size : Inapplicable

                            Deal Type : Inapplicable

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth